Nurix therapeutics CFO Hans van Houte sells $66,524 in shares
Nurix Therapeutics CFO Hans van Houte sold 2,845 shares to cover tax withholding obligations from restricted stock unit vesting, totaling approximately $66,524. This transaction occurred as the stock trades near its 52-week high and has seen a 98% gain over the past year. Concurrently, Mr. van Houte acquired 10,180 shares through RSU vesting, increasing his direct holdings to 44,927 shares.
Alignment Healthcare Turns Profit As Insurer Gets Handle On Costs
Alignment Healthcare reported a significant increase in its second-quarter net income, more than doubling to $36.6 million, primarily due to lower medical costs for its Medicare Advantage members. The company's medical benefit ratio improved to 86%, marking a second consecutive quarter of decline in this key metric. Total revenue surged over 31% to $1.3 billion, driven by a 31% rise in Medicare Advantage plan membership, reaching 294,100.
Cigna’s profits jump thanks to employer-sponsored plans
Cigna's second-quarter results indicate a significant profit jump, primarily driven by its employer-sponsored health plans. The company subsequently raised its 2026 earnings outlook, defying concerns regarding rising costs from surprise billing dispute resolutions that had affected peers like UnitedHealth. Despite acknowledging potential abuses in the independent dispute resolution process, Cigna reported a net income of $1.7 billion, an 8% year-over-year increase, largely due to better margins in its U.S. employer business, and plans to further invest in this sector after exiting ACA exchanges and its Medicare division.
Molina Healthcare Number of Employees 2026 | Employee Count & Headcount Data
Molina Healthcare, Inc. (MOH) had approximately 18,853 total employees worldwide as of March 2026, marking a 1.0% decline from 19,051 employees in 2023. Despite this, the company is actively hiring, with 1,406 active job postings in 2026, a 41.9% increase from 2025. The workforce is primarily concentrated in the United States, and the average employee salary is $97,362, with sentiment reported as negative but improving.
MOLINA HEALTHCARE, INC. : WELLS FARGO CUTS TARGET PRICE TO $220 FROM $235
Wells Fargo has lowered its target price for Molina Healthcare, Inc. from $235 to $220. This adjustment in the target price suggests a revised outlook by the financial institution on the company's future performance or valuation. The article, sourced from Reuters, reports on this change in analyst rating.
Molina Healthcare Inc (MOH) Institutional Confidence
Molina Healthcare Inc (MOH) has an institutional shareholding score of 10.00, ranking 1st in the Healthcare Providers & Services industry. The institutional shareholding proportion is 106.83%, with a slight quarter-over-quarter decrease. David G. Herro is the largest institutional shareholder, holding 1.88% of outstanding shares.
MOH5414064 Bond Risk Profile
This article provides a risk profile for the Molina Healthcare, Inc. 3.875% 15-MAY-2032 bond (MOH5414064), offering an overview of its coupon, redemption risks, and credit risk assessment metrics. It highlights key factors like security level, inflation protection, and issuer rating to help investors make informed decisions. The page also mentions access to exclusive analyst ratings for bonds.
MOH5414064 Bond Profile — Key Metrics
This article provides a bond profile for MOH5414064, a Molina Healthcare, Inc. bond with a 3.875% coupon rate maturing on May 15, 2032. Key metrics include an issue date of November 16, 2021, an outstanding amount of $750 million USD, and a face value of $1,000 USD. Molina Healthcare, Inc. is described as a healthcare services provider founded in 1980.
UnitedHealth's Cost-Control Story is Gaining Momentum: Time to Buy?
UnitedHealth (UNH) is regaining investor confidence after a challenging period, marked by improved second-quarter 2026 results and a higher full-year outlook. The company's focus on cost control has led to a healthier medical care ratio and exceeded earnings estimates. Despite a valuation slightly above historical levels and ongoing regulatory scrutiny, UnitedHealth's diversified business model, strong cash flow, and industry tailwinds position it for continued gains.
CMS fraud war room stops $203M in debated Medicaid payments
The newly established Medicaid Fraud War Room, a joint federal-state initiative,
Johnson Fistel, PLLP Begins Investigation on Behalf of
Johnson Fistel, PLLP is investigating potential claims on behalf of long-term shareholders of Methode Electronics, Inc. (MEI), Molina Healthcare, Inc. (MOH), Monolithic Power Systems, Inc. (MPWR), and NET Power Inc. (NPWR). The firm alleges breaches of fiduciary duty by officers and directors, stemming from previously filed securities class action complaints detailing various operational and financial misrepresentations. Shareholders who held stock continuously prior to specific dates may be eligible for corporate governance reforms and financial recovery.
MOH|Molina Healthcare Inc|Price:199.480|Chg%:+1.930
Molina Healthcare Inc (MOH) shows relatively healthy fundamentals and significant growth potential, although its valuation is considered fairly valued within the Healthcare Providers & Services industry. Analysts rate it a "Hold" with a target price indicating upside, despite recent weak stock market performance. The company specializes in managed healthcare services through Medicaid, Medicare, and state insurance marketplaces.
Molina Healthcare of Michigan and the MSMS Foundation to Provide Shortage Area Scholarships
Molina Healthcare of Michigan and the MSMS Foundation are partnering to offer four $10,000 scholarships to healthcare students. These scholarships aim to address the shortage of healthcare professionals in underserved Michigan communities. Eligible students must demonstrate financial need, academic promise, and a commitment to community-based care, with preference given to those intending to practice in Michigan's shortage areas.
MOLINA HEALTHCARE INC : JP MORGAN RAISES TARGET PRICE TO $220 FROM $191
JP Morgan has increased its target price for Molina Healthcare Inc (MOH.N) to $220, up from the previous target of $191. This update reflects an adjusted outlook on the healthcare provider's stock. The news was reported by Reuters.
MOLINA HEALTHCARE INC : JP MORGAN RAISES TARGET PRICE TO $220 FROM $191
JP Morgan has increased its target price for Molina Healthcare Inc. (MOH.N) to $220, up from the previous $191. This update reflects the analyst's revised outlook on the healthcare company's valuation. The article, sourced from Reuters, reports only this target price adjustment without further details or analysis.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Molina Healthcare, Inc. (MOH) And Encourages Stockholders to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Molina Healthcare, Inc. (MOH) on behalf of investors who purchased securities prior to February 5, 2025, and still hold them. The investigation focuses on whether Molina or its officers and directors engaged in corporate wrongdoing. The firm encourages affected stockholders to connect with them for more information, emphasizing that they operate on a contingency fee basis.
Molina Healthcare, Inc. Revenue Breakdown – SWB:MHG
Molina Healthcare, Inc. (SWB:MHG) generated 38.68 billion EUR in revenue last year, with its Medicaid segment being the top performer at 27.45 billion EUR. The United States was the primary geographic contributor, accounting for the entire 38.68 billion EUR. The company's revenue slightly decreased from the previous year in both the Medicaid segment and total U.S. contributions.
Molina Healthcare, Inc. Revenue Breakdown – XETR:MHG
Molina Healthcare, Inc. (MHG) generated 38.68 billion EUR in revenue last year, with its top-performing Medicaid segment contributing 27.45 billion EUR. The United States was the primary source of revenue, accounting for the entire 38.68 billion EUR. This information is based on financial data provided by FactSet and ICE Data Services.
Molina Healthcare Inc. stock underperforms Friday when compared to competitors
Molina Healthcare Inc. (MOH) stock fell 1.37% on Friday, closing at $197.55, despite a positive trading session for the broader market. This marks the fourth consecutive day of losses for the company, as the S&P 500 Index and Dow Jones Industrial Average both saw gains.
MOLINA HEALTHCARE INC : DEUTSCHE BANK RAISES TARGET PRICE TO $147 FROM $129
Deutsche Bank has increased its target price for Molina Healthcare Inc (MOH.N) to $147 from $129. This update reflects the analyst's revised outlook on the healthcare company's valuation. The news was reported by Reuters.
Deutsche Bank Adjusts Molina Healthcare Price Target to $147 From $129, Maintains Hold Rating
Deutsche Bank has updated its price target for Molina Healthcare (MOH) shares, raising it to $147 from the previous $129, while maintaining a Hold rating on the stock. This adjustment comes amidst other analyst actions, including RBC and Truist also updating their price targets for Molina Healthcare. The healthcare provider has recently seen its shares drop after reporting Q2 adjusted earnings and revenue falls, alongside news of cutting its Obamacare business.
Truist Cuts Price Target on Molina Healthcare to $225 From $250, Keeps Hold Rating
Truist has lowered its price target for Molina Healthcare (MOH) to $225 from $250, while maintaining a Hold rating on the stock. This adjustment reflects a more conservative outlook for the managed healthcare provider. The unchanged Hold rating suggests that the firm sees the stock as fairly valued at the revised target.
Cantor Fitzgerald maintains Molina Healthcare stock rating at Neutral
Cantor Fitzgerald has reiterated a Neutral rating for Molina Healthcare Inc. (NYSE:MOH) with a $209.00 price target, following concerns about the company's ability to meet its 2029 targets due to HIX margin compression and book shrinkage. Despite recent better-than-expected Q2 2026 earnings and revenue, challenges in the Marketplace segment and profitability pressures, as indicated by a low gross profit margin, are tightening the company's outlook. The firm also noted a non-typical Medicaid update further contributing to a tighter 2026 bridge.
HCA Healthcare beats estimates but cuts guidance
HCA Healthcare (NYSE:HCA) reported second-quarter results that surpassed analyst expectations but lowered its full-year guidance due to an unfavorable payer mix shift and declining surgical volumes. The company's adjusted EPS of $7.59 and revenue of $20.23 billion beat estimates, but full-year EPS and revenue guidance were cut, primarily impacted by an increase in uninsured patients. Despite these challenges, HCA experienced increased admissions and emergency room visits, and recognized incremental benefits from Medicaid Supplemental Payment Programs.
RBC Lowers Price Target on Molina Healthcare to $218 From $248, Keeps Sector Perform Rating
RBC has lowered its price target for Molina Healthcare (MOH) to $218 from $248, while maintaining a Sector Perform rating on the stock. This adjustment comes amidst news of Molina Healthcare sharply cutting its Obamacare business due to rising costs, despite lifting its annual profit forecast. The article also mentions recent Q2 earnings results and other analyst adjustments for the company.
Molina Healthcare stock trades steadily as Medicaid and marketplace growth support margins
Molina Healthcare's stock performance is supported by stable Medicaid membership and growing Affordable Care Act marketplace enrollment, with recent financial reports showing increased revenue and EPS. The company's focus on government-sponsored programs makes it sensitive to policy changes and contract renewals, but its disciplined underwriting, stable medical cost ratios, and strategic acquisitions contribute to profitable growth. Investors monitor membership trends, cost ratios, and regulatory developments to assess the stock's valuation.
Molina Healthcare Posts Lower Profit, Revenue as Membership Declines
Molina Healthcare reported a significant drop in profit and revenue for its second quarter, with net income falling to $60 million from $255 million a year earlier. The decline was attributed to decreased membership, lower premium revenue, and an increase in the medical care ratio, primarily impacting its Medicare and Medicaid operations.
MOLINA HEALTHCARE INC : RBC CUTS TARGET PRICE TO $218 FROM $248
RBC Capital Markets has reduced its target price for Molina Healthcare Inc. (MOH.N) from $248 to $218. This change in target price reflects an updated outlook from the investment bank regarding the healthcare company's valuation. The article, sourced from Reuters, details this adjustment without further explanation.
BABA Stock Price | Analyst Target 198.42 & Strong Buy Consensus
Alibaba-ADR (BABA) currently trades at $111.48, down 2.26% today, with analysts setting a Strong Buy consensus and a target price of $198.42. The company, headquartered in Hangzhou, China, operates globally through various segments including Core Commerce, Cloud Computing, and Digital Media and Entertainment. Alibaba Group Holding Ltd (BABA) is described as a "Strong Buy" based on analyst consensus, with a target price of $198.42, despite its recent share price decline.
Molina Healthcare Inc Stock 12‑Month Price Target Raised to $212.53, Implies 4% Downside
Molina Healthcare Inc's average price target has been raised slightly to $212.53 by 17 analysts, ranging from $142 to $286 per share. This new target suggests a 4% potential downside from its Jul. 22 closing price. The consensus rating from 23 analysts remains "Hold," with 5 Buy, 17 Hold, and 1 Sell recommendations.
Is Molina Healthcare Inc (MOH) a Bargain After 9.7% Drop? GF Val
Molina Healthcare Inc (MOH) shares recently fell 9.7% to $200.29, despite GuruFocus's GF Value™ indicating it is significantly undervalued with a potential upside of 50.6%. The company boasts a strong GF Score™ of 83/100, though its current P/E ratio is higher than its historical median. Insider selling totaling $3.4 million in the last three months, without any buying, suggests caution for potential investors.
Molina Healthcare Inc. stock underperforms Thursday when compared to competitors
Molina Healthcare Inc. (MOH) stock slipped 9.67% on Thursday, closing at $200.29, and underperformed its competitors. This decline occurred during a generally poor trading session for the stock market, with both the S&P 500 Index and Dow Jones Industrial Average also falling. This marks the third consecutive day of losses for Molina Healthcare.
MOLINA HEALTHCARE INC : RBC CUTS TARGET PRICE TO $218 FROM $248
RBC has reduced its target price for Molina Healthcare Inc. (MOH.N) from $248 to $218. This news was reported by Reuters on July 24, 2026. The article itself is a very brief financial news snippet, primarily relaying this single piece of information.
Molina Healthcare Inc (MOH) Q2 2026 Earnings Call Highlights: Strong Medicaid Performance Amid ...
Molina Healthcare Inc. (MOH) reported strong Q2 2026 results, with adjusted EPS of $1.51 and premium revenue of $10.2 billion, driven by robust Medicaid and improved Medicare performance. The company increased its full-year 2026 adjusted EPS guidance but faced challenges and reduced guidance for its Marketplace segment due to unfavorable acuity mix and prior-year risk adjustment issues. Molina plans to reduce its Marketplace footprint in 2027 to address these concerns, while navigating regulatory challenges and the impact of the new Florida CMS contract.
MOH Q2 Earnings Beat on Lower Operating Expenses, 2026 EPS View Raised
Molina Healthcare, Inc. (MOH) reported Q2 2026 adjusted earnings per share of $1.51, surpassing the Zacks Consensus Estimate, despite a 72.4% decline from the prior year. The company's revenues decreased by 4.8% year over year to $10.9 billion. The earnings beat was primarily driven by lower operating expenses, though this was partly offset by reduced premium revenues, declining membership, and weaker investment income. The company also raised its full-year 2026 adjusted earnings guidance to at least $5.25 per diluted share.
Molina Faces Very High Uncertainty Around a Range of Potential Profit Scenarios
Molina Healthcare, Inc. (MOH) is facing significant uncertainty regarding its future profit scenarios, according to a Morningstar analyst note published by Julie Utterback. The company specializes in at-risk medical insurance plans for government programs and focuses on managing medical and administrative costs. Morningstar had previously noted investor concerns following lowered marketplace expectations and the company's ambitious 2029 financial targets.
Form 10-Q MOLINA HEALTHCARE, INC. For: Jun 30
Molina Healthcare, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting a decrease in net income and operating income compared to the previous year, primarily due to lower premium revenue, an increased medical care ratio (MCR), and a $93 million impairment charge related to exiting the MAPD product. The company's membership decreased across all segments, with notable reductions in Medicaid and Marketplace, driven by market contraction and strategic adjustments. Despite these challenges, Molina Healthcare remains in compliance with financial covenants and aims to restore target margins through product and pricing strategies.
HCA Healthcare earnings in focus as payer mix pressures mount
HCA Healthcare is poised to report second-quarter earnings, facing scrutiny despite beating revenue and earnings expectations due to concerns over worsening insurance coverage and patient volumes. The hospital operator pre-announced results, revealing a significant "payer mix shift" due to rising uninsured patients and subsequently lowered its full-year profit guidance. Investors will be
Molina Healthcare Tops Q2 2026 Profit Forecast With $1.51 EPS
Molina Healthcare Inc. (NYSE:MOH) reported Q2 2026 adjusted earnings of $1.51 per share, surpassing the $1.40 consensus forecast by 7.9%. Despite beating profit expectations, the company experienced a 4.8% decline in revenue year-over-year, generating $10.87 billion, which led to a 6.3% drop in its stock price. Investors are concerned about the contracting topline growth and are looking for evidence of revenue stabilization to allay fears about future profitability.
Earnings call transcript: Molina Healthcare beats Q2 2026 EPS, shares fall premarket
Molina Healthcare reported stronger-than-expected Q2 2026 results with adjusted EPS of $1.51 and revenue of $10.87 billion, surpassing Wall Street estimates. Despite the beat, the company's shares fell 5.29% in premarket trading due to a weaker Marketplace outlook and other forward pressures, leading investors to prioritize future guidance over current performance. The company raised its full-year 2026 adjusted EPS guidance to at least $5.25, driven by strong Medicaid and Medicare duals performance, even as its Marketplace segment faces continued pressure from adverse selection and prior-year items.
UnitedHealth Just Beat Estimates by 30%. Wall Street Wants More.
UnitedHealth Group (UNH) surpassed Q2 adjusted earnings estimates by 30% and raised its full-year EPS guidance, primarily due to better-than-expected medical cost ratios and strong performance from its Optum unit. Despite this beat, Wall Street analysts have a modest mean target of $475, a 10% increase from the current price, while TIKR's model projects a 68% return by 2030, valuing the stock at $723. The company faces ongoing challenges with commercial insurance cost trends due to arbitration linked to the No Surprises Act.
Molina Healthcare Releases Q2 2026 Financial Results
Molina Healthcare, Inc. (MOH) reported adjusted earnings of $1.51 per share for Q2 2026, exceeding analyst estimates of $1.40 by 7.9%. While revenue decreased by 4.8% year-over-year to $10.87 billion, the company still surpassed profit forecasts. The Medicaid segment remained the largest revenue driver, and the company served 4.9 million members.
Molina Healthcare Releases Q2 2026 Financial Results
Molina Healthcare reported strong Q2 2026 results, with adjusted earnings of $1.51 per share, beating estimates by 7.9%. Despite a 4.8% decrease in revenue to $10.87 billion compared to Q2 2025, the company's Medicaid segment remained a key driver, contributing $8.05 billion. The managed care organization served 4.9 million members and exceeded earnings expectations due to improved cost management.
Molina Healthcare Earnings Beat Estimates. The Medicaid Insurer Is Confronting Investor Doubts. -- Barrons.com
Molina Healthcare reported first-quarter earnings that surpassed Wall Street expectations, with adjusted earnings per share of $5.92 against an estimated $5.68. The company is facing investor doubts regarding its medical cost trend in Medicaid and its future growth prospects. Despite these concerns, Molina affirmed its full-year earnings guidance, signaling confidence in its operational performance.
Molina Healthcare stock falls as first-half EPS covers 73.5% of 2026 floor
Molina Healthcare (NYSE:MOH) shares dropped 9.4% after hours despite an earnings beat and higher guidance, primarily because its first-half adjusted EPS of $3.86 already covers 73.5% of its $5.25 full-year floor for 2026, suggesting limited upside potential. The company's medical care ratio rose, driven by higher Marketplace MCR and increased medical costs, diverging from peers like UnitedHealth. Investors reacted to the perceived lack of future upside and the need for proof that margins are turning amid cost pressures and a decline in premium revenue and membership.
Molina: Q2 Earnings Snapshot
Molina Healthcare Inc. reported a second-quarter profit of $60 million, or $1.19 per share. Adjusted earnings were $1.51 per share, surpassing Wall Street expectations of $1.37 per share. Despite missing revenue forecasts, the company projects full-year earnings of $5.25 per share.
Molina: Q2 Earnings Snapshot
Molina Healthcare Inc. (MOH) reported a second-quarter profit of $60 million, or $1.19 per share. Adjusted earnings were $1.51 per share, surpassing analyst expectations of $1.37 per share. The company's revenue for the period was $10.87 billion, slightly missing Street forecasts, and it projects full-year earnings of $5.25 per share.
Molina Healthcare slides nearly 7% on weak revenue outlook despite topping Q2 estimates
Molina Healthcare (NYSE:MOH) shares dropped nearly 7% after hours despite surpassing Q2 analyst expectations for earnings and revenue. The decline was driven by the company maintaining its full-year revenue guidance at $42 billion, significantly below the $44.28 billion analyst estimate. Although Molina raised its full-year adjusted EPS guidance, the weak revenue outlook overshadowed the otherwise solid performance in its Medicaid and Medicare segments.
Earnings Flash (MOH) Molina Healthcare, Inc. Posts Q2 Adjusted EPS $1.51 per Share, vs. FactSet Est of $1.39
Molina Healthcare, Inc. (MOH) announced Q2 adjusted EPS of $1.51 per share, surpassing FactSet's estimate of $1.39. This financial update indicates a stronger-than-expected performance in earnings for the second quarter. The article also mentions the company's Q2 revenue of $10.87 billion, which also exceeded the FactSet estimate of $10.83 billion.
Molina Healthcare earnings in focus as guidance decision looms
Molina Healthcare (NYSE: MOH) is set to report second-quarter earnings, with analysts anticipating a solid performance despite challenging year-over-year comparisons. The main focus for investors will be whether the Medicaid insurer will raise its full-year guidance, which currently stands at "at least $5.00 per share," given a wave of recent analyst upgrades and expectations of an upward revision. Operating efficiency and longer-term Medicaid rate trends are also key areas of investor attention.
